Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs
- Coronavirus – latest updates
- See all our coronavirus coverage
Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m doses.
The US drugmaker Johnson & Johnson announced on Friday that its vaccine – which requires only one dose – is effective. This followed Thursday’s news that the Novavax vaccine, which will be manufactured in the UK, performed well in phase 3 trials.
Continue reading…